Supplemental material
OncoImmunology
Volume 12, 2023 - Issue 1
Open access
1,203
Views
1
CrossRef citations to date
0
Altmetric
Brief Report
Plasma galectins and metabolites in advanced head and neck carcinomas: evidence of distinct immune characteristics linked to hypopharyngeal tumors
Bao-Tram Thi Trana CNRS UMR 9018-METSY, Gustave Roussy and Université Paris-Saclay, Villejuif, Francehttps://orcid.org/0000-0001-7954-696XView further author information
, Aurore Gelina CNRS UMR 9018-METSY, Gustave Roussy and Université Paris-Saclay, Villejuif, FranceView further author information
, Sylvère Durandb Plateforme de Métabolomique/UMR 1138, Gustave Roussy and Université Paris-Saclay, Villejuif, Francehttps://orcid.org/0000-0001-6356-1006View further author information
, Matthieu Texierc Service d’Epidémiologie et de Biostatistiques, Gustave Roussy and Université Paris-Saclay, Villejuif, FranceView further author information
, Amaury Dasted Department of Medical Oncology, Hôpital Saint André, Bordeaux, FranceView further author information
, Clémence Toullece GI and Liver/Head and Neck unit, Institut du Cancer-Avignon Provence, Avignon, Francehttps://orcid.org/0000-0003-1733-6945View further author information
, Karim Benihouda CNRS UMR 9018-METSY, Gustave Roussy and Université Paris-Saclay, Villejuif, Francehttps://orcid.org/0000-0002-9672-5019View further author information
, Ingrid Breuskinf Service de Cancérologie Cervico-Faciale, Gustave Roussy, Villejuif, FranceView further author information
, Philippe Gorphef Service de Cancérologie Cervico-Faciale, Gustave Roussy, Villejuif, FranceView further author information
, Florence Garicg Department R&D, Unicancer, Paris cedex 13, FranceView further author information
, Catherine Brennera CNRS UMR 9018-METSY, Gustave Roussy and Université Paris-Saclay, Villejuif, Francehttps://orcid.org/0000-0002-7715-0934View further author information
, Christophe Le Tourneauh Department of Drug Development and Innovation (D3i), Institut Curie and Paris-Saclay University, Paris, Francehttps://orcid.org/0000-0001-9772-4686View further author information
, Jérôme Fayettei Claude Bernard Lyon 1 University, INSERM 1052, CNRS 5286 & Department of Medical Oncology, Centre Léon Bérard, Cancer Research Center of Lyon, Lyon, FranceView further author information
, Toshiro Nikij Department of Immunology, Kagawa University, Kita-gun, Japanhttps://orcid.org/0000-0003-4531-1331View further author information
, Muriel Davidk HiFiBiO Therapeutics, Pépinière Paris Santé Cochin, Paris, Francehttps://orcid.org/0000-0003-1392-2701View further author information
, Pierre Bussona CNRS UMR 9018-METSY, Gustave Roussy and Université Paris-Saclay, Villejuif, FranceCorrespondence[email protected]
https://orcid.org/0000-0003-1027-3400View further author information
& https://orcid.org/0000-0003-1027-3400View further author information
Caroline Evenf Service de Cancérologie Cervico-Faciale, Gustave Roussy, Villejuif, FranceView further author information
show all
Article: 2150472
|
Received 06 Jun 2022, Accepted 17 Nov 2022, Published online: 17 Dec 2022
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.